| Modifiable pathways for colorectal cancer: a mendelian randomisation analysis AJ Cornish, PJ Law, M Timofeeva, K Palin, SM Farrington, C Palles, ... The lancet Gastroenterology & hepatology 5 (1), 55-62, 2020 | 107 | 2020 |
| Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms PH Hoang, SE Dobbins, AJ Cornish, D Chubb, PJ Law, M Kaiser, ... Leukemia 32 (11), 2459-2470, 2018 | 83 | 2018 |
| Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer G Orlando, PJ Law, AJ Cornish, SE Dobbins, D Chubb, P Broderick, ... Nature genetics 50 (10), 1375-1380, 2018 | 72 | 2018 |
| Genomic landscape of platinum resistant and sensitive testicular cancers C Loveday, K Litchfield, PZ Proszek, AJ Cornish, F Santo, M Levy, ... Nature Communications 11 (1), 2189, 2020 | 59 | 2020 |
| Impact of atopy on risk of glioma: a Mendelian randomisation study L Disney-Hogg, AJ Cornish, A Sud, PJ Law, B Kinnersley, DI Jacobs, ... BMC medicine 16, 1-13, 2018 | 57 | 2018 |
| Signatures of TOP1 transcription-associated mutagenesis in cancer and germline MAM Reijns, DA Parry, TC Williams, F Nadeu, RL Hindshaw, ... Nature 602 (7898), 623-631, 2022 | 55 | 2022 |
| SANTA: quantifying the functional content of molecular networks AJ Cornish, F Markowetz PLOS Computational Biology 10 (9), e1003808, 2014 | 55 | 2014 |
| Mutational processes contributing to the development of multiple myeloma PH Hoang, AJ Cornish, SE Dobbins, M Kaiser, RS Houlston Blood cancer journal 9 (8), 60, 2019 | 51 | 2019 |
| Mendelian randomisation: a powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer AJ Cornish, IPM Tomlinson, RS Houlston Molecular aspects of medicine 69, 41-47, 2019 | 50 | 2019 |
| Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features P Robbe, KE Ridout, DV Vavoulis, H Dréau, B Kinnersley, N Denny, ... Nature genetics 54 (11), 1675-1689, 2022 | 46 | 2022 |
| Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis CN Saunders, AJ Cornish, B Kinnersley, PJ Law, EB Claus, D Il’Yasova, ... Neuro-oncology 22 (2), 207-215, 2020 | 40 | 2020 |
| PhenoRank: reducing study bias in gene prioritization through simulation AJ Cornish, A David, MJE Sternberg Bioinformatics 34 (12), 2087-2095, 2018 | 40 | 2018 |
| Search for multiple myeloma risk factors using Mendelian randomization M Went, AJ Cornish, PJ Law, B Kinnersley, M van Duin, N Weinhold, ... Blood advances 4 (10), 2172-2179, 2020 | 39 | 2020 |
| Influence of obesity-related risk factors in the aetiology of glioma L Disney-Hogg, A Sud, PJ Law, AJ Cornish, B Kinnersley, QT Ostrom, ... British journal of cancer 118 (7), 1020-1027, 2018 | 39 | 2018 |
| The genomic landscape of 2,023 colorectal cancers AJ Cornish, AJ Gruber, B Kinnersley, D Chubb, A Frangou, G Caravagna, ... Nature 633 (8028), 127-136, 2024 | 36* | 2024 |
| Relationship between genetically determined telomere length and glioma risk CN Saunders, B Kinnersley, R Culliford, AJ Cornish, PJ Law, RS Houlston Neuro-oncology 24 (2), 171-181, 2022 | 33 | 2022 |
| Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9 AF Schmidt, MV Holmes, D Preiss, DI Swerdlow, S Denaxas, G Fatemifar, ... BMC cardiovascular disorders 19, 1-10, 2019 | 32 | 2019 |
| Mendelian randomization provides support for obesity as a risk factor for meningioma H Takahashi, AJ Cornish, A Sud, PJ Law, L Disney-Hogg, L Calvocoressi, ... Scientific reports 9 (1), 309, 2019 | 31 | 2019 |
| Genome-wide association analysis identifies a meningioma risk locus at 11p15. 5 EB Claus, AJ Cornish, P Broderick, JM Schildkraut, SE Dobbins, ... Neuro-oncology 20 (11), 1485-1493, 2018 | 27 | 2018 |
| Mendelian randomisation study of the relationship between vitamin D and risk of glioma H Takahashi, AJ Cornish, A Sud, PJ Law, B Kinnersley, QT Ostrom, ... Scientific reports 8 (1), 2339, 2018 | 26 | 2018 |
Richard HoulstonThe Institute of Cancer ResearchBestätigte E-Mail-Adresse bei icr.ac.uk